Background/Aims: The prevalence and pathogenicity of TT virus, recently ide
ntified in patients with non A-non G post-transfusional hepatitis, are ques
tioned.
Methods: We investigated the impact of this new viral infection in a large
series of patients with non A-non G, cryptogenic, non-viral and viral-relat
ed, acute and chronic liver diseases (n=577) and blood donors (n=300). TTV
DNA was detected in serum by hemi-nested polymerase chain reaction, Phyloge
netic analysis was performed in 13 isolates.
Results: TTV DNA was detected in 6/25 and 15/127 patients with cryptogenic
non A-non G acute and chronic liver disease, respectively. TTV DNA positive
subjects with post-transfusional acute hepatitis scored negative before tr
ansfusion. TTV prevalence was increased in patients with cryptogenic non A-
non G acute and chronic liver disease compared to blood donors (6/300; p<0.
001) and non-viral-related chronic liver diseases (6/137; p<0.05), TTV/HBV
coinfection was frequently identified (35/147), but this was not the case f
or HCV-infected subjects (4/77), Transaminase activity or liver histologica
l score was not significantly increased among TTV positive, HBV infected or
non A-non G patients. The HBV infection and Mediterranean origin were the
risk factors associated with TTV infection. The majority of analysed sequen
ces clustered in genotype 1 (8=1b; 3=1a). Two isolates showed homology do g
enotype 2.
Conclusions: These results support the view that TTV is a widely spread inf
ectious agent with a weak pathogenicity, It raises the possibility, however
, that TTV might be implicated in a few cases of acute and chronic non A-no
n G hepatitis. TTV-DNA-analysed sequences are related to genotypes 1 and 2
described in Europe.